Target intelligence / Profile preview

Dual specificity protein phosphatase 8 (DUSP8)

Target
DUSP8
Molecular classification
Enzyme, Phosphatase, Protein tyrosine phosphatase (PTP), Dual specificity phosphatase (DUSP)
01

Overview

Dual specificity protein phosphatase 8 (DUSP8) is an enzyme that belongs to the dual specificity phosphatase family, capable of dephosphorylating both phosphoserine/threonine and phosphotyrosine residues on mitogen-activated protein kinases (MAPKs), specifically acting as a negative regulator of the JNK, ERK, and p38 MAPK pathways[1][2][4][5]. DUSP8 is predominantly expressed in adult brain, heart, and skeletal muscle, and localizes to both the cytoplasm and nucleus[1][2][4]. Its expression and activity are regulated by stimuli such as nerve growth factor and insulin, and it plays a crucial role in modulating cellular stress responses, proliferation, differentiation, and apoptosis[4][5]. Aberrant expression or loss of DUSP8 is associated with a range of human diseases, including cancer (e.g., breast, colorectal, lung), diabetic kidney disease, acute lung injury, and neuropsychiatric conditions, and its expression levels are emerging as both disease biomarkers and potential therapeutic targets[4].

Other names
C11orf81HVH-5M3/6HB5HVH8Dual specificity phosphatase 8Homologue of Vaccinia virus H1 phosphatase gene clone 5
02

Mechanism of action

Dephosphorylation of MAPKs (JNK, ERK, p38) leading to their inactivation[1][2][4][5] Modulation of cell proliferation, apoptosis, and stress responses by controlling MAPK pathway activity[2][4]

03

Biological functions

Signal transductionNegative regulation of MAPK signaling (JNK, ERK, p38)Cellular proliferation and differentiationCellular stress responseApoptosis regulation
04

Disease associations

CancerInflammationDiabetic kidney diseaseNeuropsychiatric conditions (e.g., anxiety, spatial learning)Drug resistance (e.g., breast cancer)Acute lung injury
05

Safety considerations

Potential for unwanted effects on cell growth and survival if aberrantly modulated (may influence cancer progression, neurodevelopment, or tissue injury repair)[4]Aberrant DUSP8 activity could contribute to drug resistance in cancer[4]
06

Biomarkers

DUSP8 expression (as a biomarker for disease progression and drug resistance in some cancers)DUSP8 expression as a marker in diabetic nephropathy[4]

Beyond the preview

Go deeper on Dual specificity protein phosphatase 8 (DUSP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dual specificity protein phosphatase 8 (DUSP8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call